Newborn Screening Market Size, Share, Trends, Growth Outlook

Newborn Screening Market is estimated to increase at a Compounded Annual Growth Rate of 8.5% CAGR over the forecast period from 2024 to 2030

The Newborn Screening Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Consumables, Instruments, Accessories, Devices, Pulse oximeters), By Test (Dry blood spot tests, Hearing screening tests, CCHD screening tests), By Technology (Immune assays & enzymatic assays, Tandem mass spectrometry, Molecular assays, Hearing screening technologies, Pulse oximetry, Others), By End-User (Clinical Laboratories, Hospitals).

An Introduction to Newborn Screening Market in 2024

In 2024, the market for newborn screening continues to expand, driven by the global commitment to early detection and intervention for congenital disorders, metabolic conditions, and genetic diseases in newborns. Newborn screening programs aim to identify infants at risk of serious health conditions shortly after birth, allowing for timely intervention, treatment, and management to prevent adverse outcomes and improve long-term health outcomes. Screening tests typically involve collecting blood samples via heel prick or umbilical cord blood shortly after birth and analyzing them for markers of metabolic disorders, endocrine disorders, hemoglobinopathies, and other genetic conditions. Technological advancements in newborn screening include the development of high-throughput screening platforms, tandem mass spectrometry (MS/MS), next-generation sequencing (NGS), and multiplexed assays, enabling simultaneous analysis of multiple biomarkers and expansion of screening panels to include a broader range of disorders. Moreover, the integration of digital health platforms, electronic medical records (EMRs), and telemedicine facilitates data management, follow-up, and coordination of care between healthcare providers, laboratories, and families. With the increasing emphasis on early intervention, precision medicine, and population health initiatives, the market for newborn screening is poised for continued growth and innovation, offering essential tools for identifying and addressing health risks in the most vulnerable members of society, ensuring a healthy start for newborns worldwide.

Market Trend: Expansion of Newborn Screening Programs Worldwide

A significant trend in the newborn screening market is the expansion of newborn screening programs worldwide. Governments and healthcare organizations are increasingly recognizing the importance of early detection and intervention for congenital disorders, metabolic conditions, and genetic diseases in newborns. As a result, there is a growing adoption of comprehensive newborn screening panels that encompass a wide range of conditions, including phenylketonuria (PKU), congenital hypothyroidism, cystic fibrosis, and sickle cell disease. This trend reflects a global effort to improve newborn health outcomes through early identification of treatable conditions, driving the demand for newborn screening tests, technologies, and infrastructure to support expanded screening initiatives.

Market Driver: Focus on Preventive Healthcare and Early Disease Detection

A key driver for the newborn screening market is the growing emphasis on preventive healthcare and early disease detection in newborns. Newborn screening enables healthcare providers to identify infants at risk of certain genetic, metabolic, and congenital disorders before symptoms appear, allowing for early intervention and treatment to prevent or mitigate adverse health outcomes. Early detection of conditions such as metabolic disorders, hearing loss, and critical congenital heart defects can significantly impact long-term health outcomes and quality of life for affected infants. As healthcare systems prioritize preventive measures and early intervention strategies, there is a heightened demand for newborn screening programs and technologies that enable timely and accurate identification of at-risk newborns, driving market growth and investment in newborn screening services and solutions.

Market Opportunity: Integration of Next-Generation Sequencing (NGS) in Newborn Screening

An emerging opportunity within the newborn screening market lies in the integration of next-generation sequencing (NGS) technologies. NGS offers the potential to revolutionize newborn screening by enabling comprehensive genomic analysis for a wide range of genetic disorders in a single test. By sequencing the entire exome or targeted gene panels, NGS can detect a broader spectrum of genetic conditions with higher sensitivity and specificity compared to traditional screening methods. The integration of NGS into newborn screening programs presents an opportunity to expand screening panels, improve diagnostic accuracy, and enhance early detection of rare and complex genetic disorders. Furthermore, advances in bioinformatics and data analysis tools facilitate the interpretation of NGS results and enable personalized treatment approaches based on individual genomic profiles. Collaboration between NGS technology providers, healthcare institutions, and regulatory agencies can accelerate the adoption of NGS-based newborn screening protocols, ultimately improving health outcomes for newborns and their families.

Newborn Screening Market Share Analysis: Tandem Mass Spectrometry (TMS) is the fastest growing segment over the forecast period to 2030

Among the segments of the Newborn Screening Market, Tandem Mass Spectrometry (TMS) emerges as the fastest-growing segment, driven by several factors. TMS technology offers high sensitivity and specificity, enabling the simultaneous detection of multiple metabolic disorders from a single blood sample. This capability is particularly crucial in newborn screening, where early detection of metabolic disorders is vital for timely intervention and effective management to prevent adverse health outcomes. TMS allows for the accurate quantification of various analytes, expanding the scope of newborn screening beyond traditional assays. Moreover, advancements in TMS instrumentation and software algorithms enhance its performance, reliability, and throughput, further driving its adoption in clinical laboratories and hospitals. With increasing recognition of the clinical utility and cost-effectiveness of TMS-based newborn screening programs, coupled with ongoing technological innovations, the Tandem Mass Spectrometry segment is poised for significant growth in the Newborn Screening Market.

Newborn Screening Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBaebies, Bio-Rad Laboratories Inc, Chromsystems Instruments & Chemicals GmbH, Danaher Corp, Demant A/S, Medtronic plc, Natus Medical Inc, Parseq Lab SRL, PerkinElmer Inc, Recipe Chemicals + Instruments GmbH, Trivitron Healthcare

Newborn Screening Market Segmentation

By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Newborn Screening Market Companies

Baebies
Bio-Rad Laboratories Inc
Chromsystems Instruments & Chemicals GmbH
Danaher Corp
Demant A/S
Medtronic plc
Natus Medical Inc
Parseq Lab SRL
PerkinElmer Inc
Recipe Chemicals + Instruments GmbH
Trivitron Healthcare

Reasons to Buy the Newborn Screening Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Newborn Screening Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Newborn Screening Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Newborn Screening Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Newborn Screening Market Size Outlook, $ Million, 2021 to 2030
3.2 Newborn Screening Market Outlook by Type, $ Million, 2021 to 2030
3.3 Newborn Screening Market Outlook by Product, $ Million, 2021 to 2030
3.4 Newborn Screening Market Outlook by Application, $ Million, 2021 to 2030
3.5 Newborn Screening Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Newborn Screening Industry
4.2 Key Market Trends in Newborn Screening Industry
4.3 Potential Opportunities in Newborn Screening Industry
4.4 Key Challenges in Newborn Screening Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Newborn Screening Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Newborn Screening Market Outlook by Segments
7.1 Newborn Screening Market Outlook by Segments, $ Million, 2021- 2030
By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals

8 North America Newborn Screening Market Analysis and Outlook To 2030
8.1 Introduction to North America Newborn Screening Markets in 2024
8.2 North America Newborn Screening Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Newborn Screening Market size Outlook by Segments, 2021-2030
By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals

9 Europe Newborn Screening Market Analysis and Outlook To 2030
9.1 Introduction to Europe Newborn Screening Markets in 2024
9.2 Europe Newborn Screening Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Newborn Screening Market Size Outlook by Segments, 2021-2030
By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals

10 Asia Pacific Newborn Screening Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Newborn Screening Markets in 2024
10.2 Asia Pacific Newborn Screening Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Newborn Screening Market size Outlook by Segments, 2021-2030
By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals

11 South America Newborn Screening Market Analysis and Outlook To 2030
11.1 Introduction to South America Newborn Screening Markets in 2024
11.2 South America Newborn Screening Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Newborn Screening Market size Outlook by Segments, 2021-2030
By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals
12 Middle East and Africa Newborn Screening Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Newborn Screening Markets in 2024
12.2 Middle East and Africa Newborn Screening Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Newborn Screening Market size Outlook by Segments, 2021-2030
By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Baebies
Bio-Rad Laboratories Inc
Chromsystems Instruments & Chemicals GmbH
Danaher Corp
Demant A/S
Medtronic plc
Natus Medical Inc
Parseq Lab SRL
PerkinElmer Inc
Recipe Chemicals + Instruments GmbH
Trivitron Healthcare

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Consumables
-Assay kits & reagents
-Others
Instruments
-Disorder screening instruments
-Hearing screening instruments
Accessories
Devices
Pulse oximeters
By Test
Dry blood spot tests
Hearing screening tests
CCHD screening tests
By Technology
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Others
By End-User
Clinical Laboratories
Hospitals
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)